The liquidity position of the company remains strong with our cash and investments at holding company at $1,800,000,000 at December 31, 2023, principally held in cash and short dated investments and access to our facility of $2,000,000,000 fully undrawn. At December 31, 2023, the excess of fair carrying value of our investments in non insurance associates and market traded consolidated non insurance subsidiary was $1,000,000,000 compared to $310,000,000 at December 31, 'twenty 2, with $315,000,000 of that increase related to publicly traded Eurobank. The pretax excess of $1,000,000,000 is not reflected in the company's book value per share, but is regularly reviewed by management as an indicator of investment performance. The company's debt to cap ratio, excluding our non insurance companies, improved to 23.1 percent at December 31, 'twenty three, compared to 23.7% at December 31, 'twenty two, reflecting increased common shareholders' equity as a result of the record net earnings that we reported in 'twenty three, and this was partially offset by the issuance of our $400,000,000 principal amount of the 6% unsecured notes and the recognition of a note payable of $579,000,000 relating to the Gulf acquisition. And lastly, our common shareholders' equity increased by $3,800,000,000 to $21,600,000,000 at December 31, 'twenty 3, from $17,800,000,000 at December 31, 'twenty two, principally as a result of the company's record net earnings attributable to shareholders of Fairfax for the full year of 'twenty three of $4,400,000,000 That was partially offset by the payments of common share and preferred dividends of $291,000,000 and the purchase of approximately 111,000 of subordinate voting shares for treasury and 365,000 for cancellation for aggregate cash consideration of 363,000,000 or approximately at $7.64 per share.